Notis-McConarty Edward’s Merck MRK Stock Holding History

Notis-McConarty Edward’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.22M	Hold	10,150	–	–	0.61%	36
2025 Q4	$1.07M	Hold	10,150	–	–	0.5%	41
2025 Q3	$852K	Sell	10,150 -200	-2%	-$16.5K	0.4%	47
2025 Q2	$819K	Hold	10,350	–	–	0.4%	47
2025 Q1	$929K	Hold	10,350	–	–	0.48%	42
2024 Q4	$1.03M	Hold	10,350	–	–	0.5%	44
2024 Q3	$1.18M	Sell	10,350 -1,250	-11%	-$149K	0.53%	43
2024 Q2	$1.44M	Sell	11,600 -1,400	-11%	-$180K	0.56%	43
2024 Q1	$1.72M	Sell	13,000 -3,350	-20%	-$413K	0.68%	39
2023 Q4	$1.78M	Sell	16,350 -1,550	-9%	-$161K	0.71%	37
2023 Q3	$1.84M	Hold	17,900	–	–	0.75%	38
2023 Q2	$2.07M	Sell	17,900 -100	-0.6%	-$11.4K	0.79%	37
2023 Q1	$1.92M	Sell	18,000 -70	-0.4%	-$7.56K	0.76%	38
2022 Q4	$2M	Sell	18,070 -100	-0.6%	-$10.2K	0.83%	36
2022 Q3	$1.56M	Sell	18,170 -15	-0.1%	-$1.34K	0.7%	41
2022 Q2	$1.66M	Hold	18,185	–	–	0.69%	46
2022 Q1	$1.49M	Sell	18,185 -200	-1%	-$15.8K	0.53%	53
2021 Q4	$1.41M	Sell	18,385 -200	-1%	-$15.9K	0.47%	57
2021 Q3	$1.4M	Sell	18,585 -100	-0.5%	-$7.61K	0.51%	54
2021 Q2	$1.45M	Sell	18,685 -897	-5%	-$66.7K	0.54%	54
2021 Q1	$1.44M	Sell	19,582 -16	-0.1%	-$1.18K	0.56%	52
2020 Q4	$1.53M	Sell	19,598 -314	-2%	-$24K	0.62%	49
2020 Q3	$1.58M	Buy	19,912 +52	+0.3%	+$4.07K	0.69%	46
2020 Q2	$1.47M	Sell	19,860 -262	-1%	-$19.7K	0.68%	46
2020 Q1	$1.48M	Sell	20,122 -314	-2%	-$24.7K	0.82%	41
2019 Q4	$1.77M	Sell	20,436 -314	-2%	-$25.8K	0.79%	42
2019 Q3	$1.67M	Sell	20,750 -367	-2%	-$29.4K	0.78%	42
2019 Q2	$1.69M	Sell	21,117 -26	-0.1%	-$1.99K	0.8%	41
2019 Q1	$1.68M	Sell	21,143 -1,101	-5%	-$82.3K	0.81%	39
2018 Q4	$1.62M	Sell	22,244 -791	-3%	-$55.8K	0.89%	33
2018 Q3	$1.56M	Hold	23,035	–	–	0.83%	37
2018 Q2	$1.33M	Sell	23,035 -262	-1%	-$14.8K	0.79%	41
2018 Q1	$1.21M	Sell	23,297 -629	-3%	-$34K	0.73%	43
2017 Q4	$1.28M	Buy	23,926 +4,087	+21%	+$227K	0.74%	45
2017 Q3	$1.21M	Sell	19,839 -314	-2%	-$19K	0.76%	44
2017 Q2	$1.23M	Sell	20,153 -105	-0.5%	-$6.39K	0.8%	40
2017 Q1	$1.23M	Sell	20,258 -524	-3%	-$31.8K	0.81%	42
2016 Q4	$1.17M	Sell	20,782 -602	-3%	-$35.2K	0.8%	42
2016 Q3	$1.27M	Sell	21,384 -53	-0.2%	-$3.1K	0.87%	41
2016 Q2	$1.18M	Sell	21,437 -105	-0.5%	-$5.59K	0.83%	42
2016 Q1	$1.09M	Sell	21,542 -104	-0.5%	-$5.09K	0.77%	43
2015 Q4	$1.09M	Hold	21,646	–	–	0.78%	42
2015 Q3	$1.02M	Buy	21,646 +26	+0.1%	+$1.38K	0.76%	42
2015 Q2	$1.18M	Sell	21,620 -210	-1%	-$11.8K	0.79%	42
2015 Q1	$1.2M	Hold	21,830	–	–	0.83%	40
2014 Q4	$1.18M	Hold	21,830	–	–	0.81%	39
2014 Q3	$1.24M	Sell	21,830 -1,153	-5%	-$64.7K	0.87%	37
2014 Q2	$1.27M	Sell	22,983 -104	-0.5%	-$5.67K	0.84%	39
2014 Q1	$1.25M	Sell	23,087 -210	-0.9%	-$10.9K	0.87%	39
2013 Q4	$1.11M	Buy	+23,297	New	+$1.06M	0.78%	42

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Notis-McConarty Edward's MRK Position: Q1 2026 in Review

Notis-McConarty Edward held its Merck (MRK) position steady in Q1 2026 at 10,150 shares worth $1.22M. The position accounts for 0.61% of the portfolio, ranked #36.

Notis-McConarty Edward first reported a position in MRK in Q4 2013 and has held it in 50 quarters since. The position peaked at $2.07M in Q2 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Notis-McConarty Edward held 10,150 shares of Merck worth $1.22M as of Q1 2026.
Notis-McConarty Edward left its Merck share count unchanged in Q1 2026.
Merck made up 0.61% of Notis-McConarty Edward's portfolio in Q1 2026, its #36 holding.
Notis-McConarty Edward first reported a position in Merck in Q4 2013 and has held it in 50 quarters since.
Notis-McConarty Edward's Merck position peaked at $2.07M in Q2 2023.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Notis-McConarty Edward's 13F filing for Q1 2026, filed 8 May 2026.